Date: August 12, 2020 Source 1: Harvard Medical School Source 2: www.sciencedaily.com Summary: New drug regimen for multidrug-resistant tuberculosis shows early effectiveness in 85 percent of patients in a cohort including many with serious comorbidities. The results suggest a global need for expanded access to two recently developed medicines, bedaquiline and delamanid. Study cohort included
Date: July 13, 2020 Source 1: Michigan Medicine – University of Michigan Source 2: www.sciencedaily.com Summary: Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off ventilator within a month, despite double the risk of additional infection, according to a new study. Critically ill COVID-19 patients
Study suggests clinicians should include sensory impairment as standard screening measure Date: April 13, 2020 Source 1: University of California – San Diego Source 2 : www.sciencedaily.com Summary: Researchers have published the first empirical findings that strongly associate sensory loss and COVID-19, the respiratory disease caused by the novel coronavirus. Loss of smell and taste
